肿瘤药理学、临床药学及药物治疗学、临床试验机构（GCP）管理

1. Hong X#, Zhang J#, Zou J#, Ouyang J, Xiao B, Wang P*, Peng X*: Role of COL6A2 in malignant progression and temozolomide resistance of glioma. CELL SIGNAL 2023, 102:110560.

2. Wang P#, Zhang J#, He S, Xiao B, Peng X*: SLC39A1 contribute to malignant progression and have clinical prognostic impact  in gliomas. CANCER CELL INT 2020, 20(1):573.

3. Wang P#, Peng X#, Zhang J, Wang Z, Meng J, Cen B, Ji A, He S*: LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the  JAK/STAT pathway. APOPTOSIS 2018, 23(11-12):651-666.

4. 王鹏#, 李文适, 彭小彬, 陈莉婧, 张忠义, 王勇, 贺帅*: 金翘热毒清颗粒体外抗炎作用研究. 中药材 2018, 41(10):2435-2437.